Characterization of health monitoring patterns in patients with metabolic diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032126

Enrollment

300

Registered

2023-06-26

Start date

2023-11-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic fatty liver disease

Interventions

Group 1: Patients with Nonalcoholic fatty liver disease (NAFLD) and Type 2 Diabetes (T2DM) Group 2: Patients with NAFLD and without T2DM Group 3: Patients without any metabolic disease

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria for all groups are an age of at least 18 years and the ability to give informed consent to participate. The following specific inclusion and exclusion criteria apply to the arms: confirmed NAFLD diagnosis and exclusion of T2DM confirmed NAFLD diagnosis and confirmed T2DM diagnosis Exclusion of metabolic diseases

Exclusion criteria

Exclusion criteria: Use of liver toxic drugs, parenteral nutrition, liver cirrhosis, viral hepatitis, autoimmune hepatitis, hemochromatosis, short bowel syndrome, Wilson's disease, increased alcohol consumption (daily more than 10g for women or 20g for men). In addition, people with walking disabilities should not be included because physical activity profiles (steps per unit time) are measured.

Design outcomes

Primary

Measure	Time frame
After four weeks of monitoring	—

Countries

Germany

Contacts

Public ContactMartin Mücke

Institut für Digitale Allgemeinmedizin

mamuecke@ukaachen.de+49241-888 07 101

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026